Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B.
Huang YW, Hsu CW, Lu SN, Yu ML, Su CW, Su WW, Chien RN, Hsu CS, Hsu SJ, Lai HC, Qin A, Tseng KC, Chen PJ.
Huang YW, et al. Among authors: hsu cs, hsu cw, hsu sj.
Hepatol Int. 2020 Dec;14(6):997-1008. doi: 10.1007/s12072-020-10098-y. Epub 2020 Oct 24.
Hepatol Int. 2020.
PMID: 33099752
Free PMC article.
Clinical Trial.